Shares Of Epizyme Of Cambridge Skyrocket 80%, After Pair Of Positive DevelopmentsEpizyme stock soared on Tuesday, after the company announced two important payments from its partners in the development of new types of cancer drugs.

More From CBS Boston

Download Weather App
Taz Show

Listen Live